Many Duchenne muscular dystrophy patients in the U.S. have imported a medicine called deflazacort for about $1,200 a year. A brand-name version just approved for sale in America costs $89,000.
The two healthcare giants said they were no longer pursuing the deal. A federal judge blocked the merger in January, citing its likely adverse effect on competition in the health insurance market.
A federal judge issued a preliminary injunction barring the government from enforcing a rule allowing insurers to refuse to insure dialysis patients who get financial assistance from charity groups.
Morning Consult Chief Research Officer Kyle Dropp talks about a recent survey which shows one third of respondents are still confused about the Affordable Care Act and what repealing it would mean.
International groups warn of a looming food crisis in parts of Nigeria due to civil conflict. Children are the most vulnerable in these conditions, but up to 9 million people could be affected.
Across the U.S., anti-abortion protesters flocked to clinics to demand the defunding of Planned Parenthood. In many cities, supporters showed up to counterprotest — sometimes right across the street.
NPR's Scott Simon talks to the Republican former Rep. Richard Hanna about the Affordable Care Act. Hanna says despite Trump's pledge to repeal it, he thinks the ACA will largely survive.
A quarter of doctors practicing in the U.S. went to medical school elsewhere. Many of these physicians practice in parts of this country that the government says need more primary care providers.
Citing a Kaiser Health News investigation, Sen. Chuck Grassley, chairman of the Senate Judiciary Committee, will examine potential abuses of incentives to spur development of drugs for rare diseases.